complement C3 analog (Cascade)

N/A

Report date: 2025/03/18 18:19:41

Base Information

Drug Namecomplement C3 analog (Cascade)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionComplement C3 stimulants
TargetsComplement C3
Therapy Area/IndicationsHemoglobinuria, Paroxysmal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCascade Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesCascade Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsHemoglobinuria, Paroxysmal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A